NZ193421A - Preparation of isopropylaminopyrimidine hydroxy derivatives pharmaceutical compositions - Google Patents

Preparation of isopropylaminopyrimidine hydroxy derivatives pharmaceutical compositions

Info

Publication number
NZ193421A
NZ193421A NZ193421A NZ19342180A NZ193421A NZ 193421 A NZ193421 A NZ 193421A NZ 193421 A NZ193421 A NZ 193421A NZ 19342180 A NZ19342180 A NZ 19342180A NZ 193421 A NZ193421 A NZ 193421A
Authority
NZ
New Zealand
Prior art keywords
isopropylaminopyrimidine
preparation
pharmaceutical compositions
hydroxy derivatives
derivatives pharmaceutical
Prior art date
Application number
NZ193421A
Inventor
A Esanu
Original Assignee
Soc D Etudes Prod Chimique
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Soc D Etudes Prod Chimique filed Critical Soc D Etudes Prod Chimique
Publication of NZ193421A publication Critical patent/NZ193421A/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
    • C07D239/24—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
    • C07D239/28—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
    • C07D239/46—Two or more oxygen, sulphur or nitrogen atoms
    • C07D239/47—One nitrogen atom and one oxygen or sulfur atom, e.g. cytosine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P21/00—Drugs for disorders of the muscular or neuromuscular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
    • C07D239/24—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
    • C07D239/28—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
    • C07D239/46—Two or more oxygen, sulphur or nitrogen atoms
    • C07D239/52—Two oxygen atoms
    • C07D239/54—Two oxygen atoms as doubly bound oxygen atoms or as unsubstituted hydroxy radicals
    • C07D239/545—Two oxygen atoms as doubly bound oxygen atoms or as unsubstituted hydroxy radicals with other hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Neurosurgery (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
  • Catalysts (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
NZ193421A 1979-04-30 1980-04-11 Preparation of isopropylaminopyrimidine hydroxy derivatives pharmaceutical compositions NZ193421A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB7914987 1979-04-30

Publications (1)

Publication Number Publication Date
NZ193421A true NZ193421A (en) 1981-11-19

Family

ID=10504858

Family Applications (2)

Application Number Title Priority Date Filing Date
NZ193422A NZ193422A (en) 1979-04-30 1980-04-11 Preparation of hydroxy-isopropylamino pyrimidines pharmaceutical compositions
NZ193421A NZ193421A (en) 1979-04-30 1980-04-11 Preparation of isopropylaminopyrimidine hydroxy derivatives pharmaceutical compositions

Family Applications Before (1)

Application Number Title Priority Date Filing Date
NZ193422A NZ193422A (en) 1979-04-30 1980-04-11 Preparation of hydroxy-isopropylamino pyrimidines pharmaceutical compositions

Country Status (26)

Country Link
JP (2) JPS55145670A (en)
AR (2) AR222870A1 (en)
AT (2) AT380012B (en)
BE (2) BE882593A (en)
CH (2) CH645633A5 (en)
DK (2) DK183880A (en)
EG (2) EG14259A (en)
ES (2) ES8103060A1 (en)
FI (2) FI66359C (en)
FR (2) FR2455589A1 (en)
GB (2) GB2054556B (en)
HK (2) HK55583A (en)
IE (2) IE49709B1 (en)
IN (2) IN154067B (en)
IT (2) IT1141487B (en)
LU (2) LU82333A1 (en)
MA (1) MA18824A1 (en)
MX (2) MX5878E (en)
MY (2) MY8400204A (en)
NL (2) NL8002271A (en)
NO (2) NO154056C (en)
NZ (2) NZ193422A (en)
OA (2) OA06527A (en)
PT (2) PT71155A (en)
SG (2) SG22283G (en)
ZA (2) ZA801958B (en)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS63145595U (en) * 1987-03-13 1988-09-26
JPS645795U (en) * 1987-06-26 1989-01-13
JPH01100695U (en) * 1987-12-21 1989-07-06
HU206337B (en) * 1988-12-29 1992-10-28 Mitsui Petrochemical Ind Process for producing pyrimidine derivatives and pharmaceutical compositions
US5264435A (en) * 1988-12-29 1993-11-23 Mitsui Petrochemical Industries, Ltd. Pyrimidines and their pharmaceutical acceptable salts, and their use as medicines

Also Published As

Publication number Publication date
HK55583A (en) 1983-11-25
ES490999A0 (en) 1981-02-16
SG22283G (en) 1983-12-16
NO154056C (en) 1986-07-09
MY8400204A (en) 1984-12-31
IT1141296B (en) 1986-10-01
ATA221580A (en) 1985-08-15
JPS6116272B2 (en) 1986-04-28
AR222870A1 (en) 1981-06-30
NO801234L (en) 1980-10-31
IT8021542A0 (en) 1980-04-22
EG14259A (en) 1983-09-30
IE800865L (en) 1980-10-30
ZA801960B (en) 1981-04-29
FI801083A (en) 1980-10-31
BE882594A (en) 1980-07-31
LU82332A1 (en) 1980-07-02
FI66358C (en) 1984-10-10
GB2054556B (en) 1983-01-26
MY8400203A (en) 1984-12-31
JPS6116273B2 (en) 1986-04-28
NL8002271A (en) 1980-11-03
NL8002272A (en) 1980-11-03
CH645361A5 (en) 1984-09-28
MX5878E (en) 1984-08-16
NO801235L (en) 1980-10-31
OA06525A (en) 1981-07-31
IN154067B (en) 1984-09-15
FI801084A (en) 1980-10-31
IE49709B1 (en) 1985-11-27
IE800864L (en) 1980-10-30
FR2455588A1 (en) 1980-11-28
BE882593A (en) 1980-07-31
FR2455588B1 (en) 1983-04-15
PT71154A (en) 1980-05-01
ZA801958B (en) 1981-04-29
IE49591B1 (en) 1985-10-30
AT380013B (en) 1986-03-25
AR222869A1 (en) 1981-06-30
IN154066B (en) 1984-09-15
AT380012B (en) 1986-03-25
DK183880A (en) 1980-10-31
HK55683A (en) 1983-11-25
DK183780A (en) 1980-10-31
NZ193422A (en) 1981-12-15
GB2054556A (en) 1981-02-18
ES8103061A1 (en) 1981-02-16
FI66359C (en) 1984-10-10
GB2055801A (en) 1981-03-11
SG22583G (en) 1983-12-16
NO154055B (en) 1986-04-01
JPS55145670A (en) 1980-11-13
IT1141487B (en) 1986-10-01
NO154055C (en) 1986-07-09
MA18824A1 (en) 1980-12-31
ES8103060A1 (en) 1981-02-16
FI66358B (en) 1984-06-29
EG14284A (en) 1983-09-30
ATA221680A (en) 1985-08-15
ES491000A0 (en) 1981-02-16
MX6514E (en) 1985-06-26
FI66359B (en) 1984-06-29
FR2455589A1 (en) 1980-11-28
PT71155A (en) 1980-05-01
FR2455589B1 (en) 1981-07-10
LU82333A1 (en) 1980-07-02
GB2055801B (en) 1983-02-09
CH645633A5 (en) 1984-10-15
NO154056B (en) 1986-04-01
IT8021543A0 (en) 1980-04-22
OA06527A (en) 1981-07-31
JPS55145671A (en) 1980-11-13

Similar Documents

Publication Publication Date Title
GB8315756D0 (en) Preparation of activated pharmaceutical compositions
NZ188320A (en) Thienothiazine derivatives preparation and pharmaceutical compositions
IL60555A0 (en) Pharmaceutical compositions containing certain ureal derivatives
IL58978A0 (en) Peptidyl-arginne aldehyde derivatives their preparation and pharmaceutical compositions containing them
IL56411A (en) Derivatives of 4-amino-5-alkylsulphonyl-ortho-anisamides,their preparation and pharmaceutical compositions containing them
MY8500075A (en) Novel derivatives of glycerin their preparation and pharmaceutical compositions containing them
IL61307A (en) Derivatives of 6beta-hydroxyalkylpenicillanic acids,their preparation and pharmaceutical compositions containing them
MY8700186A (en) 3-aminopropoxyaryl derivatives their preparation and pharmaceutical compositions containing them
NZ193798A (en) 3-thiovinyl-cephalosporin derivatives and pharmaceutical compositions
IL59770A (en) Pharmaceutical compositions containing 3-alkoxy-flavone derivatives,some novel compounds of this type and their preparation
DE3072103D1 (en) Pharmaceutical compositions containing 3-amino-pyrazoline derivatives
NZ192927A (en) Hydroxy derivatives of 2-isopropylamino-pyrimidine pharmaceutical compositions
NZ190810A (en) 1-aminoalkyl-3-phenoxy-propan-2-ol derivatives pharmaceutical compositions
NZ194784A (en) 7 -aminothiadizolylacetylamino-3-cephem-4-carboxylic acid derivatives and pharmaceutical compositions
NZ193344A (en) Pyran-4-one derivatives and pharmaceutical compositions
PT72066A (en) Process for the preparation of novel halophenyl-pyridil-allylamine derivatives and pharmaceutical compositions thereof
IL58620A0 (en) Aryltrifluoroethanol derivatives their preparation and pharmaceutical compositions containing them
NZ194490A (en) 25-halocholest-5-ene-3 22-diol derivatives pharmaceutical compositions
NZ193421A (en) Preparation of isopropylaminopyrimidine hydroxy derivatives pharmaceutical compositions
NZ193557A (en) 4-phenylchroman derivatives intermediates and pharmaceutical compositions
GB2041915B (en) Preparation of bromo-p-terphenyl derivatives
ZA817568B (en) Derivatives of piperazine:procedure for their preparation and related pharmaceutical compositions
IL58438A0 (en) Isoquinoline derivatives their preparation and pharmaceutical compositions containing them
NZ194122A (en) Acylaminobenzoic acid derivatives and pharmaceutical compositions
NZ191718A (en) Preparation of derivatives of diisoeugenols certain of these derivatives pharmaceutical compositions